Individual results may vary
Resources
Individual results may vary
Resources
Sign up for the latest news about GIVLAARI® (givosiran)
All fields are required.
Looking for more info? Download the GIVLAARI brochure.
Frequently asked questions about GIVLAARI
There are probably a lot of things you want to know about GIVLAARI. Below you can find some answers to frequently asked questions. This information is not intended to replace discussions with your healthcare provider.
Choose a topic from one of the categories below and click on it to get more information.
- GIVLAARI is a prescription medicine used to treat AHP in adults. There are 4 types of AHP:
- Acute intermittent porphyria (AIP)
- Hereditary coproporphyria (HCP)
- Variegate porphyria (VP)
- ALA-dehydratase deficient porphyria (ADP)
- Most patients in GIVLAARI clinical studies had AIP, the most common type of AHP
GIVLAARI is given once a month as a subcutaneous injection (under the skin) by a healthcare professional.
If you miss a dose, talk to your doctor about scheduling your next dose as soon as possible.
GIVLAARI can cause liver and kidney problems.
- Your doctor will check your liver function by doing blood tests:
- Before you start using GIVLAARI
- Once a month for the first 6 months of treatment
- And when they think it is needed
- If these tests show abnormal results, your doctor or nurse will decide whether to temporarily interrupt or stop treatment with GIVLAARI
- Your doctor will check how your kidneys are working while you are using GIVLAARI
GIVLAARI has not been studied in women who are pregnant. If you are pregnant or plan to become pregnant, it is important to discuss your treatment plan with your doctor.